211 related articles for article (PubMed ID: 30308177)
1. Dropwise Additive Manufacturing of Pharmaceutical Products Using Particle Suspensions.
Radcliffe AJ; Hilden JL; Nagy ZK; Reklaitis GV
J Pharm Sci; 2019 Feb; 108(2):914-928. PubMed ID: 30308177
[TBL] [Abstract][Full Text] [Related]
2. Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems.
Içten E; Purohit HS; Wallace C; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
Int J Pharm; 2017 May; 524(1-2):424-432. PubMed ID: 28380390
[TBL] [Abstract][Full Text] [Related]
3. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
[TBL] [Abstract][Full Text] [Related]
4. Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms.
Içten E; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
J Pharm Sci; 2015 May; 104(5):1641-9. PubMed ID: 25639605
[TBL] [Abstract][Full Text] [Related]
5. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
Bonhoeffer B; Kwade A; Juhnke M
J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
[TBL] [Abstract][Full Text] [Related]
6. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
8. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
Lin L; Quan G; Peng T; Huang Z; Singh V; Lu M; Wu C
Int J Pharm; 2017 Nov; 533(1):84-92. PubMed ID: 28903066
[TBL] [Abstract][Full Text] [Related]
9. Particle Engineering Via Mechanical Dry Coating in the Design of Pharmaceutical Solid Dosage Forms.
Qu L; Morton DA; Zhou QT
Curr Pharm Des; 2015; 21(40):5802-14. PubMed ID: 26446461
[TBL] [Abstract][Full Text] [Related]
10. Melt milling as manufacturing method for solid crystalline suspensions.
da Igreja P; Erve A; Thommes M
Eur J Pharm Biopharm; 2021 Jan; 158():245-253. PubMed ID: 33253891
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical spray drying: solid-dose process technology platform for the 21st century.
Snyder HE
Ther Deliv; 2012 Jul; 3(7):901-12. PubMed ID: 22900470
[TBL] [Abstract][Full Text] [Related]
12. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.
Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
Pharm Res; 2015 May; 32(5):1694-703. PubMed ID: 25385690
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
14. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
Sun WJ; Aburub A; Sun CC
J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
16. Applications of capsule dosing techniques for use in dry powder inhalers.
Edwards D
Ther Deliv; 2010 Jul; 1(1):195-201. PubMed ID: 22816126
[TBL] [Abstract][Full Text] [Related]
17. Conversion of PLGA nanoparticle suspensions into solid dosage forms via fluid bed granulation and tableting.
Horster L; Bernhardt A; Kiehm K; Langer K
Eur J Pharm Biopharm; 2019 Jan; 134():77-87. PubMed ID: 30447271
[TBL] [Abstract][Full Text] [Related]
18. Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms.
Hirshfield L; Giridhar A; Taylor LS; Harris MT; Reklaitis GV
J Pharm Sci; 2014 Feb; 103(2):496-506. PubMed ID: 24311373
[TBL] [Abstract][Full Text] [Related]
19. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.
Niwa T; Miura S; Danjo K
Int J Pharm; 2011 Feb; 405(1-2):218-27. PubMed ID: 21167922
[TBL] [Abstract][Full Text] [Related]
20. Control of Drug-Excipient Particle Attributes with Droplet Microfluidic-based Extractive Solidification Enables Improved Powder Rheology.
Ng DZL; Nelson AZ; Ward G; Lai D; Doyle PS; Khan SA
Pharm Res; 2022 Feb; 39(2):411-421. PubMed ID: 35119593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]